Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medicines Company (MDCO)

Medicines Company (MDCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,708,690
  • Shares Outstanding, K 79,723
  • Annual Sales, $ 6,140 K
  • Annual Income, $ -123,160 K
  • 60-Month Beta 1.09
  • Price/Sales 1,093.76
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.90
  • Number of Estimates 6
  • High Estimate -0.74
  • Low Estimate -1.19
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -34.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.16 +71.32%
on 11/15/19
84.48 -0.31%
on 12/10/19
+29.21 (+53.10%)
since 11/08/19
3-Month
46.05 +82.89%
on 09/11/19
84.48 -0.31%
on 12/10/19
+37.66 (+80.88%)
since 09/10/19
52-Week
16.69 +404.61%
on 12/21/18
84.48 -0.31%
on 12/10/19
+63.43 (+305.10%)
since 12/10/18

Most Recent Stories

More News
BOLD, MDCO, AYR, and PEGI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

BOLD : 59.51 (+0.32%)
MDCO : 84.22 (+0.08%)
PEGI : 27.22 (-0.04%)
AYR : 32.17 (+0.22%)
Why Biotech ETFs are Surging to New Highs

increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

MRK : 89.10 (+0.43%)
SNY : 48.09 (+6.16%)
NVS : 92.80 (+0.29%)
IBB : 120.10 (+0.58%)
BBC : 36.01 (+2.36%)
SBIO : 42.46 (+1.41%)
XBI : 95.53 (+1.06%)
THOR : 67.80 (+0.13%)
MDCO : 84.22 (+0.08%)
ARQL : 19.95 (+1.27%)
AUPH : 17.70 (+12.17%)
ARKG : 34.58 (+1.05%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - MDCO, TIF, AMTD, CARO

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

MDCO : 84.22 (+0.08%)
TIF : 133.46 (-0.01%)
AMTD : 51.33 (+0.47%)
CARO : 42.19 (+1.08%)
Novartis tender offer for The Medicines Company commences

Basel, December 5, 2019 -- Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Medusa Merger Corporation, a Delaware corporation ("Purchaser"), has commenced...

NVS : 92.80 (+0.29%)
MDCO : 84.22 (+0.08%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - AMTD, TIF, MDCO, PGNX

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

AMTD : 51.33 (+0.47%)
TIF : 133.46 (-0.01%)
MDCO : 84.22 (+0.08%)
PGNX : 4.97 (-0.40%)
MDCO, IPHS, BREW, and CARB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

BREW : 16.47 (+0.03%)
IPHS : 31.89 (+0.03%)
MDCO : 84.22 (+0.08%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of THE MEDICINES COMPANY - MDCO

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating The Medicines Company...

NVS : 92.80 (+0.29%)
MDCO : 84.22 (+0.08%)
Alnylam Gets Second Product Approval Amid Stiff Competition

Alnylam (ALNY) gets FDA approval for givosiran injection for subcutaneous use to treat adults with acute hepatic porphyria. Givosiran injection will be marketed by the trade name of Givlaari.

SNY : 48.09 (+6.16%)
ALNY : 121.84 (+0.94%)
MDCO : 84.22 (+0.08%)
REGN : 367.67 (+0.56%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 129.66 (+0.29%)
XLV : 99.93 (+0.22%)
VHT : 186.94 (+0.16%)
MDCO : 84.22 (+0.08%)
LHCG : 132.25 (-1.29%)
ARWR : 70.86 (+4.56%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates The Medicines Co.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Medicines Co. ("MDCO" or the "Company") (NASDAQ: MDCO) in connection with...

NVS : 92.80 (+0.29%)
MDCO : 84.22 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MDCO with:

Business Summary

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare...

See More

Key Turning Points

2nd Resistance Point 84.63
1st Resistance Point 84.42
Last Price 84.22
1st Support Level 84.07
2nd Support Level 83.93

See More

52-Week High 84.48
Last Price 84.22
Fibonacci 61.8% 58.58
Fibonacci 50% 50.59
Fibonacci 38.2% 42.59
52-Week Low 16.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar